Skip to main content

Advertisement

Log in

Evaluation of systemic immune-inflammation index level as a novel marker for severity of noninfectious uveitis

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the association of systemic immune-inflammation index (SII) levels, neutrophil/lymphocyte ratio (NLR), and platelet/lymphocyte ratio (PLR) with severity of noninfectious uveitis.

Methods

This retrospective study included 46 patients with noninfectious uveitis (uveitis group) and 46 age- and sex-matched healthy subjects (control group). The demographic and ocular findings, localization, and activity of uveitis were recorded at the time of onset evaluation. SII, NLR, and PLR levels of patients were compared between the groups.

Results

SII, NLR, and PLR levels were significantly higher in uveitis group when compared to control group (p < 0.001, p = 0.005, and p = 0.001, respectively). While SII and NLR were significantly higher in severe anterior uveitis than mild anterior uveitis (p = 0.006 and p = 0.021, respectively), only SII was significantly higher in severe posterior and panuveitis than mild ones (p = 0.038).

Conclusion

SII, as a novel inflammation index, may be more significant tool than NLR and PLR in determining the severity of the uveitis. Furthermore, SII may be a potential useful index in clinical practice to follow-up and manage these patients by monitoring response to anti-inflammatory treatment modalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

All data are included in this paper.

References

  1. Yildiz Balci S, Turan-Vural E, Turkyilmaz O et al (2020) Complete blood count parameters and neutrophil-to-lymphocyte ratio values as markers for differentiation between systemic infectious and non-infectious uveitis. Int Ophthalmol 40(11):3033–3041

    Article  PubMed  Google Scholar 

  2. Bozkurt E, Muhafiz E, Sengul D et al (2020) Can the CRP/albumin Ratio be Used as a New Indicator of Activation in Patients with Uveitis? Ocul Immunol Inflamm 1–6.

  3. Duplechain A, Conrady CD, Patel BC et al. (2020) Uveitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.

  4. Kurtul BE, Ozer PA (2019) Neutrophil-to-lymphocyte ratio in ocular diseases: a systematic review. Int J Ophthalmol 12(12):1951–1958

    Article  PubMed  PubMed Central  Google Scholar 

  5. Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD (2019) The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med 39(4):345–357

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Yildiz Balci S, Kose AO, Yildiz MB et al (2020) Systemic inflammatory biomarkers in patients with Fuchs’ uveitis syndrome: neutrophil/lymphocyte ratio and platelet/lymphocyte ratio. J Coll Physicians Surg Pak 30(7):722–725

    Article  PubMed  Google Scholar 

  7. Hammad M, Shehata OZ, Abdel-Latif SM et al (2018) Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in Behçet’s disease: which and when to use? Clin Rheumatol 37(10):2811–2817

    Article  PubMed  Google Scholar 

  8. Gheita TA, Sakr BR, Rabea RE et al (2019) Value of hematological indices versus VEGF as biomarkers of activity in Behçet’s disease. Clin Rheumatol 38(8):2201–2210

    Article  CAS  PubMed  Google Scholar 

  9. Aziz MH, Sideras K, Aziz NA et al (2019) The systemic-immune-inflammation index independently predicts survival and recurrence in resectable pancreatic cancer and its prognostic value depends on bilirubin levels: a retrospective multicenter cohort study. Ann Surg 270(1):139–146

    Article  PubMed  Google Scholar 

  10. Zhang Y, Chen B, Wang L et al (2019) Systemic immune-inflammation index is a promising noninvasive marker to predict survival of lung cancer: a meta- analysis. Med (Baltimore) 98(3):e13788

    Article  Google Scholar 

  11. Wang P, Yue W, Li W et al (2019) Systemic immune-inflammation index and ultrasonographic classification of breast imaging-reporting and data system predict outcomes of triple-negative breast cancer. Cancer Manag Res 11:813–819

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Yang YL, Wu CH, Hsu PF et al (2020) Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest 50(5):e13230

    Article  CAS  PubMed  Google Scholar 

  13. Gok M, Kurtul A (2020) A novel marker for predicting severity of acute pulmonary embolism: systemic immune-inflammation index. Scand Cardiovasc J 2:1–6

    Google Scholar 

  14. Li S, Liu K, Gao Y et al (2020) Prognostic value of systemic immune-inflammation index in acute/subacute patients with cerebral venous sinus thrombosis. Stroke Vasc Neurol.

  15. Hou D, Wang C, Luo Y et al (2020) Systemic immune- inflammation index (SII) but not platelet-albumin-bilirubin (PALBI) grade is associated with severity of acute ischemic stroke (AIS). Int J Neurosci 1–6.

  16. Tang B, Li S, Han J, Cao W et al (2020) Associations between blood cell profiles and primary open-angle glaucoma: a retrospective case-control study. Ophthalmic Res 63(4):413–422

    Article  PubMed  Google Scholar 

  17. Ozarslan Ozcan D, Kurtul BE, Ozcan SC et al. (2020) Increased Systemic Immune Inflammation Index Levels in Patients with Dry Eye Disease. Ocul Immunol Inflamm 1–5.

  18. Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140:509–516

    Article  PubMed  Google Scholar 

  19. Nussenblatt RB, Palestine AG, Chan CC et al (1985) Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 92(4):467–471

    Article  CAS  PubMed  Google Scholar 

  20. Zhang Z, Su Q, Zhang L et al (2019) Diagnostic value of hemoglobin and neutrophil-to-lymphocyte ratio in Behcet disease. Med (Baltimore) 98(52):e18443

    Article  Google Scholar 

  21. Lee YH, Song GG (2018) Neutrophil-to-lymphocyte ratio, mean platelet volume and platelet-to-lymphocyte ratio in Behçet’s disease and their correlation with disease activity: A meta-analysis. Int J Rheum Dis 21(12):2180–2187

    Article  CAS  PubMed  Google Scholar 

  22. Ataş H, Canpolat F, Eskioglu F (2018) Evaluation of mean platelet volume in patients with Behcet’s Disease as an indicator of vascular thrombosis. Arch Iran Med 21(6):234–239

    PubMed  Google Scholar 

  23. Alan S, Tuna S, Türkoğlu EB (2015) The relation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume with the presence and severity of Behçet’s syndrome. Kaohsiung J Med Sci 31(12):626–631

    Article  PubMed  Google Scholar 

  24. Rifaioglu EN, Bülbül Şen B, Ekiz Ö (2014) Neutrophil to lymphocyte ratio in Behçet’s disease as a marker of disease activity. Acta Dermatovenerol Alp Pannonica Adriat 23(4):65–67

    PubMed  Google Scholar 

  25. Avci A, Avci D, Erden F et al (2017) Can we use the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume values for the diagnosis of anterior uveitis in patients with Behcet’s disease? Ther Clin Risk Manag 13:881–886

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Balkarli A, Kucuk A, Babur H et al (2016) Neutrophil/lymphocyte ratio and mean platelet volume in Behçet’s disease. Eur Rev Med Pharmacol Sci 20(14):3045–3050

    CAS  PubMed  Google Scholar 

  27. Haasnoot AJ, van Tent-Hoeve M, Wulffraat NM et al (2015) Erythrocyte sedimentation rate as baseline predictor for the development of uveitis in children with juvenile idiopathic arthritis. Am J Ophthalmol 159(2):372–377

    Article  PubMed  Google Scholar 

  28. Christopher J Brady, Andrea C Villanti, Hua Andrew Law et al (2016) Corticosteroid implants for chronic non‐infectious uveitis. Cochrane Database Syst Rev (2): CD010469.

  29. van Laar JAM, Rothova A, Missotten T et al (2015) Diagnosis and treatment of uveitis; not restricted to the ophthalmologist. J Clin Transl Res 1(2):94–99

    PubMed  PubMed Central  Google Scholar 

Download references

Funding

The authors declared that this study received no funding.

Author information

Authors and Affiliations

Authors

Contributions

BEK, AIC, AE, SCO, DOO, and GK contributed to conception or design of the work, the acquisition, analysis, and interpretation of data; BEK drafted the work or revised it critically for important intellectual content. BEK, AIC, AE, SCO, DOO, and GK agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Corresponding author

Correspondence to Bengi Ece Kurtul.

Ethics declarations

Conflict of interest

No conflict of interest was declared by the authors.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors. All authors approved the version to be published.

Informed consent

Informed consent was obtained from all individual participants included into the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kurtul, B.E., Cakmak, A.I., Elbeyli, A. et al. Evaluation of systemic immune-inflammation index level as a novel marker for severity of noninfectious uveitis. Int Ophthalmol 41, 3615–3622 (2021). https://doi.org/10.1007/s10792-021-01924-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-021-01924-9

Keywords

Navigation